Correlation between gene methylation status and clinical features
Acute Myeloid Leukemia (Primary blood derived cancer - Peripheral blood)
15 July 2014  |  analyses__2014_07_15
Maintainer Information
Citation Information
Maintained by Juok Cho (Broad Institute)
Cite as Broad Institute TCGA Genome Data Analysis Center (2014): Correlation between gene methylation status and clinical features. Broad Institute of MIT and Harvard. doi:10.7908/C1CR5S48
Overview
Introduction

This pipeline uses various statistical tests to identify genes whose promoter methylation levels correlated to selected clinical features.

Summary

Testing the association between 19042 genes and 4 clinical features across 194 samples, statistically thresholded by P value < 0.05 and Q value < 0.3, 3 clinical features related to at least one genes.

  • 138 genes correlated to 'AGE'.

    • TMEM20 ,  ANGPTL5 ,  KIAA1377 ,  JAKMIP1 ,  AASS ,  ...

  • 15 genes correlated to 'GENDER'.

    • DKFZP434L187 ,  AP2B1 ,  FAM35A ,  GLUD1 ,  CROCC ,  ...

  • 4 genes correlated to 'RACE'.

    • GRAP ,  FAM66D__2 ,  LOC392196 ,  CPNE7

  • No genes correlated to 'Time to Death'

Results
Overview of the results

Complete statistical result table is provided in Supplement Table 1

Table 1.  Get Full Table This table shows the clinical features, statistical methods used, and the number of genes that are significantly associated with each clinical feature at P value < 0.05 and Q value < 0.3.

Clinical feature Statistical test Significant genes Associated with                 Associated with
Time to Death Cox regression test   N=0        
AGE Spearman correlation test N=138 older N=36 younger N=102
GENDER Wilcoxon test N=15 male N=15 female N=0
RACE Kruskal-Wallis test N=4        
Clinical variable #1: 'Time to Death'

No gene related to 'Time to Death'.

Table S1.  Basic characteristics of clinical feature: 'Time to Death'

Time to Death Duration (Months) 0.9-94.1 (median=12)
  censored N = 63
  death N = 106
     
  Significant markers N = 0
Clinical variable #2: 'AGE'

138 genes related to 'AGE'.

Table S2.  Basic characteristics of clinical feature: 'AGE'

AGE Mean (SD) 55.11 (16)
  Significant markers N = 138
  pos. correlated 36
  neg. correlated 102
List of top 10 genes differentially expressed by 'AGE'

Table S3.  Get Full Table List of top 10 genes significantly correlated to 'AGE' by Spearman correlation test

SpearmanCorr corrP Q
TMEM20 -0.4691 5.241e-12 9.98e-08
ANGPTL5 -0.4301 3.881e-10 7.39e-06
KIAA1377 -0.4301 3.881e-10 7.39e-06
JAKMIP1 -0.4275 5.054e-10 9.62e-06
AASS -0.4139 1.989e-09 3.79e-05
TBC1D12 -0.3924 1.521e-08 0.00029
CD96 0.3869 2.5e-08 0.000476
CAMK2D -0.3812 4.157e-08 0.000791
CBLN3 -0.3809 4.265e-08 0.000812
KHNYN -0.3809 4.265e-08 0.000812
Clinical variable #3: 'GENDER'

15 genes related to 'GENDER'.

Table S4.  Basic characteristics of clinical feature: 'GENDER'

GENDER Labels N
  FEMALE 89
  MALE 105
     
  Significant markers N = 15
  Higher in MALE 15
  Higher in FEMALE 0
List of top 10 genes differentially expressed by 'GENDER'

Table S5.  Get Full Table List of top 10 genes differentially expressed by 'GENDER'. 0 significant gene(s) located in sex chromosomes is(are) filtered out.

W(pos if higher in 'MALE') wilcoxontestP Q AUC
DKFZP434L187 8773 6.895e-26 1.31e-21 0.9388
AP2B1 935 8.831e-22 1.68e-17 0.8999
FAM35A 968 1.999e-21 3.81e-17 0.8964
GLUD1 968 1.999e-21 3.81e-17 0.8964
CROCC 1069 2.333e-20 4.44e-16 0.8856
KIF4B 1238 1.227e-18 2.34e-14 0.8675
ATP5J 6871 1.696e-08 0.000323 0.7353
GABPA__1 6871 1.696e-08 0.000323 0.7353
LOC389791__1 6643 4.296e-07 0.00818 0.7109
PTGES2__1 6643 4.296e-07 0.00818 0.7109
Clinical variable #4: 'RACE'

4 genes related to 'RACE'.

Table S6.  Basic characteristics of clinical feature: 'RACE'

RACE Labels N
  ASIAN 2
  BLACK OR AFRICAN AMERICAN 13
  WHITE 177
     
  Significant markers N = 4
List of 4 genes differentially expressed by 'RACE'

Table S7.  Get Full Table List of 4 genes differentially expressed by 'RACE'

ANOVA_P Q
GRAP 6.63e-06 0.126
FAM66D__2 9.628e-06 0.183
LOC392196 9.628e-06 0.183
CPNE7 1.413e-05 0.269
Methods & Data
Input
  • Expresson data file = LAML-TB.meth.by_min_clin_corr.data.txt

  • Clinical data file = LAML-TB.merged_data.txt

  • Number of patients = 194

  • Number of genes = 19042

  • Number of clinical features = 4

Survival analysis

For survival clinical features, Wald's test in univariate Cox regression analysis with proportional hazards model (Andersen and Gill 1982) was used to estimate the P values using the 'coxph' function in R. Kaplan-Meier survival curves were plot using the four quartile subgroups of patients based on expression levels

Correlation analysis

For continuous numerical clinical features, Spearman's rank correlation coefficients (Spearman 1904) and two-tailed P values were estimated using 'cor.test' function in R

Student's t-test analysis

For two-class clinical features, two-tailed Student's t test with unequal variance (Lehmann and Romano 2005) was applied to compare the log2-expression levels between the two clinical classes using 't.test' function in R

ANOVA analysis

For multi-class clinical features (ordinal or nominal), one-way analysis of variance (Howell 2002) was applied to compare the log2-expression levels between different clinical classes using 'anova' function in R

Q value calculation

For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.

Download Results

In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.

References
[1] Andersen and Gill, Cox's regression model for counting processes, a large sample study, Annals of Statistics 10(4):1100-1120 (1982)
[2] Spearman, C, The proof and measurement of association between two things, Amer. J. Psychol 15:72-101 (1904)
[3] Lehmann and Romano, Testing Statistical Hypotheses (3E ed.), New York: Springer. ISBN 0387988645 (2005)
[4] Howell, D, Statistical Methods for Psychology. (5th ed.), Duxbury Press:324-5 (2002)
[5] Benjamini and Hochberg, Controlling the false discovery rate: a practical and powerful approach to multiple testing, Journal of the Royal Statistical Society Series B 59:289-300 (1995)